70 results found.
      
Orthopedic Public Companies Grow 2.6% YoY in Quarter
.article table {table-collapse: collapse;} .article table {border: 1px solid black !important;margin-bottom: 18px;} .artcle th {border: 1px solid black !important;} .article td {border: 1px solid black !important;} .article tr:last-child .article td {text-align: right;} ....
ConMed Orthopedic Revenue +Up 5.1% in 2Q19
ConMed reports 2Q19 orthopedic revenue of USD $115.8MM, +5.1% vs. 2Q18.
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
ConMed Reports 1Q19 Orthopedic Revenue of $113.4MM, +4.2% vs. 1Q18
ConMed reports 1Q19 orthopedic revenue of USD $113.4MM, +4.2% vs. 1Q18.
Revenue Review: 4Q18 and Full Year 2018 Performance Highlights for Public Companies
By Mike Evers Below you’ll find a summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies. Exhibits 1 and 2 show 4Q18 and full year performance, respectively.  Companies continue to refine their strategies to improve sales mix ...
ConMed reports 4Q18 orthopaedic revenue of $124.8MM, +3.1% vs. 4Q17
ConMed reports 4Q18 orthopaedic revenue of $124.8MM, +3.1% vs. 4Q17, with full y...
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
2018 Year in Review: Revenue Projections and Technology Trends
By Mike Evers In November, we published our downloadable report, 2018 Revenue Projections: Companies Over $200 Million, for the 25 largest orthopaedic companies, shown here in Exhibit 1. Sales for these 25 companies account for approximately 80% of the worldwide orthopaedic market. We p...
3Q18 and 9 Month 2018 Performance Highlights for Public Companies
By Mike Evers Our recap highlights 3Q18 developments and ORTHOWORLD's projection of 2018 full-year revenue for the first publicly traded orthopaedic companies to report. Exhibits 1 and 2 below show year over year company performance for 3Q18 and nine months ending September 30, 2018...
ConMed Reports 3Q18 Orthopaedic Revenue of $102.9MM, +4.4% vs. 3Q17
ConMed reports 3Q18 orthopaedic revenue of US $102.9MM, +4.4% vs. 3Q17.
Revenue Review: 1H18 Growth and 2Q18 Performance Highlights for Public Companies
by Julie A. Vetalice The 21 companies tracked below collectively grew +3.6% in 1H18 vs. 1H17, still on track to reach our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. Exhibits 1 and 2 reflect 1H18 results for public orthopaedic companies. The performan...
ConMed's 2Q18 Orthopaedic Revenue
ConMed posted 2Q18 arthroscopy/soft tissue repair revenue of US $110.1MM, +4.3% vs. 2Q17, and 1H18 revenue of $219.0MM,...
Public Orthopaedic Companies: 1Q18 Revenue and Growth Drivers
By Julie A. Vetalice The 21 companies tracked in Exhibits 1 and 2 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. (Review
Anika Therapeutics Reports 1Q18 Orthobiologic Revenue
Anika Therapeutics posted 1Q18 orthobiologic revenue of US $19.5MM, -3.6% vs. 1Q17.
ConMed 1Q18 Arthroscopy/Soft Tissue Repair Revenue
ConMed posted 1Q18 arthroscopy/soft tissue repair revenue of US $108.9MM, +4.9% vs. 1Q17. 
Public Orthopaedic Companies: 2017 Revenue and 2018 Sales Drivers
By Julie A. Vetalice The 20 companies tracked in Exhibits 1 and 2 collectively grew +3.0% in 2017 vs. 2016. Individually, you’ll notice some stellar performance in particular segments. (Our final estimates for 2017 orthopaedic industry revenue can be found in
ConMed 4Q17 Arthroscopy/Soft Tissue Revenue +8% vs. 4Q16
ConMed posted 4Q17 arthroscopy/soft tissue repair revenue of US $121.0MM, +8.4% vs. 4Q16, and 2017 revenue ...
Majority of Public Orthopaedic Companies Still on Track for Full-Year Guidance
By Julie A. Vetalice Looking at 3Q17 revenue and reading call transcripts, much was said about unforeseen headwinds that crept in before the close of the year, affecting orthopaedic companies in a variety of ways. Following weather events, oft-cited “softness&rdqu...
ConMed Reports 3Q17 Arthroscopy/Soft Tissue Repair Revenue
ConMed posted 3Q17 arthroscopy/soft tissue repair revenue of US $98.6MM, -0.8% vs. 3Q16, and YTD revenue
Sales Results for 20 Orthopaedic Companies: A Mid-year Status Report
By Julie A. Vetalice Now that we’ve collected 1H17 results from 20 publicly-traded companies, I’d like to share some performance-based observations. With now just 4 months remaining in the year, these companies provide a helpful gauge in projecting industry growth.
Anika Therapeutics Posts Orthobiologics Sales Growth for 2Q17/1H17
Anika Therapeutics posted 2Q17 orthobiologic revenue of US $24.5MM, +5.0% vs. 2Q16, and 1H17 revenue of
ConMed Reports 2Q17 Revenue
ConMed posted 2Q17 arthroscopy/soft tissue repair revenue of US $105.5MM, -0.3% vs. 2Q16.
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
ConMed Posts 1Q17 Revenue -1.4% vs. 1Q16
ConMed posted 1Q17 arthroscopy/soft tissue repair revenue of US $103.8MM, -1.4% vs. 1Q16. 
ConMed Company Profile
We're redesigning Company Profiles. To get the most current news and articles about ConMed in the interim, please use...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group